Related Experiment Videos
Lipoid pneumonia presenting as non resolving community acquired pneumonia: a case report
Vijay Hadda1, Gopi C Khilnani, Ashu S Bhalla
1Department of Medicine, All India Institute of Medical Sciences, New Delhi, 110029, India.
Introduction:
Lipoid pneumonia is a rare form of pneumonia caused by inhalation or aspiration of fat containing substances like, petroleum jelly, mineral oils, few laxatives etc. It usually presents as insidious onset chronic respiratory illness simulating interstitial lung diseases. Rarely, it may present as an acute respiratory illness, specially, when exposure to fatty substance is acute and/or massive. Radiologically, it may mimic carcinoma, acute or chronic pneumonia, ARDS, or a localized granuloma. Diagnosis of LP requires demonstration of lipid laden macrophages in sputum, bronchoalveolar lavage fluid or fine needle aspiration cytology/biopsy from lung lesion. Treatment of this illness is poorly defined and constitutes supportive therapy and corticosteroids.
Case Presentation:
A 20-year old Indian farmer was referred to us with a diagnosis of non resolving community acquired pneumonia. Respiratory examination revealed signs of consolidation. Chest radiograph revealed findings suggestive of bilateral consolidation. Sputum and blood culture were sterile. He was treated with prolonged course of various antibiotics without any significant response. For evaluation of non resolving pneumonia fibreoptic bronchoscopy was done. Bronchoalveolar lavage fluid and biopsy from lung lesion showed lipid laden macrophages. Hence diagnosis of lipoid pneumonia was made. Patient was treated with course of corticosteroids with good response. Literature on this rare entity is discussed.
Conclusion:
Lipoid pneumonia is a rare form of pneumonia which rarely present acutely resembling community acquired pneumonia and requires high degree of suspicion for diagnosis. Its treatment is difficult and poorly defined. However, prolonged corticosteroids may be effective.
Insights
Lipoid pneumonia, a rare lung condition, can mimic community-acquired pneumonia. Diagnosis requires identifying lipid-laden macrophages, and corticosteroids may aid treatment.
Area of Science:
- Pulmonology
- Pathology
Background:
- Lipoid pneumonia (LP) is a rare lung disease caused by inhaling or aspirating fatty substances.
- It typically presents as a chronic respiratory illness but can rarely manifest acutely, mimicking other lung conditions.
- Radiological findings can resemble carcinoma, pneumonia, or granuloma, complicating diagnosis.
Purpose of the Study:
- To present a case of lipoid pneumonia that initially mimicked non-resolving community-acquired pneumonia.
- To highlight the diagnostic challenges and treatment approaches for this rare condition.
Main Methods:
- A case study of a 20-year-old farmer with persistent pneumonia symptoms.
- Diagnostic procedures included fiberoptic bronchoscopy with bronchoalveolar lavage and lung biopsy.
- Identification of lipid-laden macrophages confirmed the diagnosis of lipoid pneumonia.
Main Results:
- The patient's condition did not improve with antibiotics, suggesting an alternative diagnosis.
- Bronchoalveolar lavage and biopsy revealed lipid-laden macrophages, confirming lipoid pneumonia.
- Treatment with corticosteroids resulted in a positive clinical response.
Conclusions:
- Lipoid pneumonia can present acutely, resembling community-acquired pneumonia, necessitating a high index of suspicion.
- Diagnosis relies on identifying lipid-laden macrophages.
- While treatment is challenging, prolonged corticosteroid therapy may be effective.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology